Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 26Colorectal Neoplasms 17Colonic Neoplasms 15Central Nervous System Neoplasms 15Rectal Neoplasms 11Glioblastoma 7Lung Neoplasms 6Kidney Neoplasms 6Gliosarcoma 6Carcinoma, Non-Small-Cell Lung 6Brain Neoplasms 6Astrocytoma 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Ovarian Epithelial 5Sarcoma 4Neoplasm Metastasis 4Melanoma 4Fallopian Tube Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Glioma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2

Interventions

Doxorubicin 4pazopanib 2Radiotherapy 2Ifosfamide 2saracatinib 1sapanisertib 1peposertib 1liposomal doxorubicin 1cixutumumab 1Specimen Handling 1Radiation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1MLN 8237 1Imatinib Mesylate 1HhAntag691 1Chemotherapy, Adjuvant 1Biopsy 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Dermatofibrosarcoma × Chemotherapy, Adjuvant × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡